Relyvrio sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension Images
Generic Name: sodium phenylbutyrate/taurursodiol
This medication has been identified as Relyvrio sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension and is used for Amyotrophic Lateral Sclerosis. It belongs to the drug class miscellaneous central nervous system agents and is not a controlled substance.
Images of medication
Relyvrio
- Generic Name
- sodium phenylbutyrate/taurursodiol
- Strength
- sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amylyx Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 73063-0035
See also:
More about Relyvrio (sodium phenylbutyrate / taurursodiol)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.